Showing 1 - 10 of 251
Persistent link: https://www.econbiz.de/10004796312
Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...
Persistent link: https://www.econbiz.de/10009434765
Established in 1988, the Shingo Prize for Operational Excellence recognises organisations in the USA, Mexico and Canada …
Persistent link: https://www.econbiz.de/10009459022
effect). This study has practical implications for regulators, corporations and investors, both in the USA and abroad. …
Persistent link: https://www.econbiz.de/10009459069
Persistent link: https://www.econbiz.de/10009638798
foreign stock of Ghanaian physicians had reduced by between 10 and 13 percent and attribute this directly to the effect of the …
Persistent link: https://www.econbiz.de/10009476584
During Peter Drucker's talk entitled "The Organization in Transition – Are the Traditional Functions Obsolete?" he discusses functions that remain centers of specialized knowledge and training, but cease to constitute the organizational base of the work itself. During his lecture, he talks...
Persistent link: https://www.econbiz.de/10009429635
This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...
Persistent link: https://www.econbiz.de/10009439017
This semiotic analysis demonstrates how pharmaceutical companies strategically frame depression within the hotly contested terrain of direct-to-consumer (DTC) advertising. The study tracks regulation of the pharmaceutical industry, relative to DTC advertising, including recent industry codes of...
Persistent link: https://www.econbiz.de/10009484498
institutional legitimacy) and to market drug-producing crops called Plant Made Pharmaceuticals (an instance of actional legitimacy …. Consumers were more slightly more likely to acknowledge the industry's right to market Plant Made Pharmaceuticals (r = .257 … as a big business entity and to market Plant Made Pharmaceuticals. …
Persistent link: https://www.econbiz.de/10009430368